LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alterationCornelis M. van Tilburg, Olaf Witt, David Capper et al.|BMC Cancer|2024Cited by 66
Phosphatidylinositol‐3′‐kinase/AKT signaling is essential in synovial sarcomaNicolaus Friedrichs, Wolfgang Hartmann, Marcel Trautmann et al.|International Journal of Cancer|2010Cited by 53
TERT promoter mutation and chromosome 6 loss define a high-risk subtype of ependymoma evolving from posterior fossa subependymomaChristian Thomas, Leonille Schweizer, Felix Thierfelder et al.|Acta Neuropathologica|2021Cited by 43
LOGGIC Core BioClinical Data Bank: Added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patientsEmily C. Hardin, Cornelis M. van Tilburg, Simone Schmid et al.|Neuro-Oncology|2023Cited by 28
The HIT-network for children and adolescents with CNS tumors facilitates improvements of diagnostic assessments, multimodal treatments, individual counselling, and research in Germany, Austria, and SwitzerlandStefan Rutkowski, Johannes Gojo, Michael Frühwald C et al.|Unknown|2025Cited by 1